Cabaletta Bio Inc (CABA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.47-0.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CABA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||||
| R&D Expenses | 157.8 | 142.7 | 97.2 | 55.4 | 39.3 | 32.5 | 21.4 | 11.7 |
| Other Operating Expenses, Total | 0.7 | 0.4 | — | — | — | — | — | — |
| Operating Income | (185.5) | (172.2) | (125.1) | (74.7) | (54.1) | (46.3) | (33.8) | (18.7) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | 2.3 | 2.0 | 0.7 | 0.0 | — | — | — | — |
| Interest & Investment Income | 5.8 | 6.0 | 10.0 | 7.0 | 1.2 | 0.0 | 0.5 | 1.7 |
| Net Interest Expenses | — | — | — | (7.0) | — | — | — | — |
| Net Income | ||||||||
| Net Income | (181.3) | (167.9) | (115.9) | (67.7) | (53.0) | (46.3) | (33.3) | (16.9) |
| Per Share | ||||||||
| Basic EPS | (1.20) | (2.10) | (2.34) | (1.65) | (1.81) | (1.80) | — | — |
| Diluted EPS | (1.20) | (2.10) | (2.34) | (1.65) | (1.81) | (1.80) | — | — |
| Dividend per Share | — | — | — | — | — | — | — | 0.00 |
| Basic Weighted Avg Shares | 151.2 | — | — | 1.2 | 5.9 | — | — | — |
| Diluted Weighted Avg Shares | 151.2 | — | — | — | — | — | — | — |
| Supplemental | ||||||||
| EBIT | (185.5) | (172.2) | (125.1) | (74.7) | (54.1) | (46.3) | (33.8) | (18.7) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.